Background: Serum creatinine (s [Cr]) reference ranges for very-low-birth-weight (VLBW) infants must account for physiologic changes in the first months of life. Methods: We retrospectively identified a sample of 218 appropriate-for-gestational age (GA) VLBW infants without risk factors for renal impairment, and classified into one of three GA groups: 25-27, 28-29, and 30-33 wk. We observed three phases of s [Cr] change (initial, decline, and equilibrium), whose characteristics varied by GA group. We used mixed-effects regression models to estimate mean and upper 95th prediction interval of s [Cr] for each GA group from birth to 34-36 wk post menstrual age (PMA). results: In phase I, s [Cr] increased after birth, then returned slowly to baseline. The duration of phase I and the magnitude of s [Cr] rise decreased with increasing GA. In phase II, s [Cr] declined abruptly at a rate that increased with GA. A gradual transition to phase III, a steady-state equilibrium with similar s [Cr] among GA groups, began at approximately 34-36 wk PMA. We constructed GA group-specific nomograms depicting s [Cr] behaviour across the three phases. conclusion: The reference ranges derived from a sample of infants without risk factors for renal impairment provide a context for quantitative interpretation of s [Cr] trends in VLBW infants. s erum creatinine concentration (s [Cr]) is the most widely used marker of renal function, specifically to make inferences about glomerular filtration rate (GFR). In very-low-birthweight (VLBW) preterm infants, interpretation of a single s [Cr] is problematic. S[Cr] changes markedly after birth, reflecting the dynamic interaction of maternal renal function, neonatal muscle mass, GFR, and slowly-maturing glomerular and tubular function, precluding a single reference range for s [Cr] values (1-11). Definitions of acute kidney injury (AKI) in the newborn based on an absolute change in s [Cr] may not account for physiologic changes in s [Cr]. For example, the absence of a physiologic decline in s [Cr] during the first month of life may represent diminished renal function. Thus, it is imperative that reference ranges accounting for physiologic changes in s [Cr] be defined (12, 13 Table 1 displays selected characteristics of infants born during the study period who were included and not included in the study. The excluded infants had significantly lower GA and birth weight (BW), and were more likely to receive positive pressure resuscitation at birth, surfactant treatment, and mechanical ventilation than the included infants. These differences reflect the increased probability of exclusion on the basis of risk for AKI among sicker, smaller infants and with lower BW and GA.
s erum creatinine concentration (s [Cr] ) is the most widely used marker of renal function, specifically to make inferences about glomerular filtration rate (GFR). In very-low-birthweight (VLBW) preterm infants, interpretation of a single s [Cr] is problematic. S[Cr] changes markedly after birth, reflecting the dynamic interaction of maternal renal function, neonatal muscle mass, GFR, and slowly-maturing glomerular and tubular function, precluding a single reference range for s [Cr] values (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) . Definitions of acute kidney injury (AKI) in the newborn based on an absolute change in s [Cr] may not account for physiologic changes in s [Cr] . For example, the absence of a physiologic decline in s [Cr] during the first month of life may represent diminished renal function. Thus, it is imperative that reference ranges accounting for physiologic changes in s [Cr] be defined (12, 13) . Although studies have described changes in s [Cr] after birth in preterm infants, their samples have often included infants with risk factors for renal impairment or have not been presented in a way that allows s[Cr]s outside a normal reference range to be easily recognized. Only a few studies have examined how gestational age (GA) influences the chronological age at which s [Cr] equilibrium is reached (8, 11) .
We report estimates of mean and upper 95th prediction interval of s [Cr] for VLBW infants with uncomplicated clinical courses as functions of gestational and postnatal age from birth to 34-36 wk postmenstrual age (PMA). Because the assessment of the pattern and progression of s[Cr] may be of far more interest to a clinician than an individual s[Cr] value, our goal was to create reference ranges that allow the assessment of s[Cr] trends. Table 1 displays selected characteristics of infants born during the study period who were included and not included in the study. The excluded infants had significantly lower GA and birth weight (BW), and were more likely to receive positive pressure resuscitation at birth, surfactant treatment, and mechanical ventilation than the included infants. These differences reflect the increased probability of exclusion on the basis of risk for AKI among sicker, smaller infants and with lower BW and GA.
RESULTS

Phases of Mean s[Cr]
Panels (a)-(c) of Figure 1 show mean s[Cr] and 95% prediction levels by GA group and the overlying profiles of s [Cr] for each infant in the group. In the week after birth, s[Cr] is highest and most variable, then declines rapidly over 3-6 wk, approaching a stable level with lower variability thereafter. The profile of s[Cr] behaviour after birth falls into three distinct phases whose characteristics vary with GA.
Phase I (initial postnatal). Mean s [Cr] increases during the first 3-4 postnatal days by 10-25% and declines slowly back to baseline over the first week of life in infants born at 25-27 wk. The magnitude of increase is greater at earlier GA. In infants born at 28 wk and later, the duration and magnitude of this initial increase in mean s[Cr] progressively diminish. 
Gentamicin Effect
Most study infants were exposed to gentamicin at some time during their hospitalization, but the exposure rate decreased as GA increased ( Table 3) . Mean duration of initial exposure and total exposure were highest in the 25-27 wk GA group.
Because gentamicin exposure was strongly associated with GA group, its effect on s[Cr] could not be distinguished from the effect of GA group in regression models.
DISCUSSION
During the first 4-8 wk of life, the behaviour of s [Cr] in VLBW infants can be empirically divided into three phases: initial, decline, and equilibrium. Although this pattern has been depicted previously by investigators (8, 9, 11, 14) , it is useful to explicitly distinguish these stages in order to emphasize their distinct physiologic differences.
Several major changes in renal function contribute to the patterns of s[Cr] change. Intense nephrogenesis occurs during the third trimester of gestation, with a normal adult complement of one million nephrons attained by 35-wk GA (5) . During this period, GFR increases logarithmically with PMA (7). Postmortem histologic studies on renal tissue from preterm infants demonstrated that nephrogenesis continues after early third-trimester preterm birth, although with a higher number of structurally abnormal glomeruli compared with GA-matched controls (15, 16) . In utero, newborn s[Cr] is in equilibrium with maternal s[Cr] (4, 17, 18) . After birth, the factors that contribute to a re-equilibration of s[Cr] reflecting the infant's own rates of creatinine metabolism and excretion are in flux (4, 17) . These include changes in systemic blood pressure, renal perfusion, capillary permeability, extracellular fluid volume, and in tubular handling of sodium, potassium, and hydrogen ions, all of which may be modified by systemic illness. Transient reabsorption of s[Cr] across leaky, immature tubules has been postulated to explain the transient increase in s[Cr] during the first week of life in very preterm infants (phase I) (19) . This effect is more pronounced in more immature (1, 3, 8, 9, 11, (19) (20) (21) (22) (23) (24) . The domeshaped initial phase in infants of 25-27 wk has been previously described (1, 8, 9, 11, 14) (11) provided tabular and graphic data on 161 infants of 22-28 wk GA including mean and 10-90th percentile ranges for the first week of life (graphic) and age 0-8 wk (tabular). Among those examined, the methodology and utility of the Thayyil study are most similar to this study. The mean values in the Thayyil's study by GA group parallel those of our study but are usually 10-15 µmol/l higher. These differences may result from the use of slightly different GA groups as well as from more inclusive entry criteria in the Thayyil study. The mean values in our study were also lower compared with several other studies, which may have included infants with risk factors for compromised renal function (1, 6, 8, 9, 14) . The exclusion criteria for these studies vary but overall were less strict than those of this study. Table 4 summarizes published studies, including their exclusion criteria and methodology (1) (2) (3) 6, 8, 9, 11, 14, (20) (21) (22) (23) (24) (25) (26) (27) (28) . The lower mean values in our study (and narrower variance estimates) may also result from adjustments due to the effects of covariates included in the predictive regression model, as well as due to the differences in s[Cr] measurement methodology. The standardization of methodology is recent and occurred after most of the studies in Table 4 were published (29, 30) .
Gentamicin was the only aminoglycoside antibiotic used in premature infants in our neonatal intensive care unit (NICU) during the study period. For infants treated longer than 72 h, gentamicin dose was adjusted, if needed, according to serum drug level. The exposure was usually brief ( Table 3) . The frequency of gentamicin exposure was similar to that of aminoglycoside exposure in other NICUs (31, 32) . Gentamicin impairs newborn renal function in term and preterm infants, increasing the fractional excretions of sodium, magnesium, calcium, and albumin (33) (34) (35) . In cell cultures, gentamicin inhibits metanephron formation and reduces glomeruli number (36) . In several clinical studies, the effect of gentamicin on s[Cr] is unclear. Giapros et al. (35) demonstrated significant differences between preterm and full-term infants treated with gentamicin for 7 d, but not between treated and untreated infants. Tugay et al. (34) showed significant differences between pretreatment, treatment, and post-treatment s[Cr] values in preterm infants (mean ± SD: 32.4 ± 3.3 wk GA) treated with gentamicin, but the difference was actually due to a decline in s[Cr] after treatment, not due to an increase. In our data, the absence of measurable association between s[Cr] and gentamicin exposure in multivariate mixed-effects models may be related to the colinearity between the GA group and gentamicin exposure and to the low power to detect significant effects in subgroups.
Both antenatal steroid exposure and postnatal exposure to caffeine have been associated with increases in creatinine clearance and urine output (37, 38) . Similar to gentamicin, antenatal steroid exposure was ubiquitous ( Table 1 ) and no significant effect was noted in exploratory regression models. Caffeine was not administered routinely in study infants (see Methods); however, detailed data on caffeine receipt for individual infants 
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Articles in our study were not available; hence, its possible effects on s[Cr] behaviour remain unknown.
Other limitations deserve mention. Although it is one of the larger studies to explore s[Cr] behaviour in VLBW infants, it includes a relatively small number of infants in the lowest GA group, and none less that 25-wk gestation. Infants of 23-24 wk GA are frequently exposed to potentially nephrotoxic medications and are more likely to have other risk factors for renal dysfunction. A reference range for s [Cr] that strictly excludes infants with risk factors for renal impairment may not be attainable for this GA group. Our dataset also lacked detailed information on maternal conditions (e.g., hypertension, diabetes, use of nephrotoxic medications, placental insufficiency, and reason for preterm delivery) that might influence postnatal newborn renal function. The infants born to mothers with severe deteriorations in their renal function and very high initial s[Cr] levels might have patterns of s [Cr] decline that deviated substantially from our nomograms simply because of the higher initial creatinine load (17) . However, although s[Cr] at birth reflects maternal renal function, peak s [Cr] in the first few days of life is a function of newborn factors, particularly GA (9). In Table 1 , we have characterized s [Cr] in the first 24-h age for each GA group. Finally, an unequal distribution of small for gestational age (SGA, BW < 10th percentile for GA (39) ) is noted in Table 1 , reflecting the use of an arbitrary cutoff (BW < 1,500 g) as the upper inclusion value for the study. To correct for this inequality, we included BW in the predictive model.
In summary, our study offers clinically useful nomograms with age-specific prediction intervals adjusted to permit assessment of s[Cr] trends as a function of GA in VLBW infants from birth through 34-36-wk PMA. It differs from prior studies in its strict exclusion of infants with risk factors for renal impairment, in its relatively large size, and in its use of regression models with locally derived variance estimates to establish an upper 95% prediction interval. Monitoring s[Cr] trends in VLBW infants may be useful in identifying infants who require special attention to fluid and electrolyte 
